Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Shares Issued (2023 - 2025)

Kura Oncology (KURA) has disclosed Shares Issued for 3 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 40.64% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, down 79.16% year-over-year, with the annual reading at $1.8 million for FY2025, 79.16% down from the prior year.
  • Shares Issued for Q4 2025 was $1.1 million at Kura Oncology, up from $515000.0 in the prior quarter.
  • The five-year high for Shares Issued was $3.0 million in Q2 2024, with the low at $84000.0 in Q3 2023.
  • Average Shares Issued over 3 years is $1.2 million, with a median of $807000.0 recorded in 2024.
  • The sharpest move saw Shares Issued surged 2521.43% in 2024, then crashed 94.4% in 2025.
  • Over 3 years, Shares Issued stood at $691000.0 in 2023, then increased by 16.79% to $807000.0 in 2024, then surged by 40.64% to $1.1 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $1.1 million, $515000.0, and $143000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.